A randomized phase 2 trial evaluated whether prophylactic goshajinkigan reduces the incidence of CIPN in patients receiving carboplatin plus paclitaxel.

In a new study, patients with intestinal inflammatory disease who received immune checkpoint inhibitor (ICI) therapy appeared to have increased risk of ...

Quarterly nursing quality summits are evaluated as a strategy to enhance leadership accountability, drive zero harm, and ...

Researchers evaluated the impact of olanzapine for CINV on CNS symptom burden in patients receiving AC-based chemotherapy.

Supported by phase 3 OASIS-4 data, elinzanetant significantly reduced daily hot flash frequency in women receiving endocrine therapy for HR-positive breast cancer.

A systematic review and meta-analysis evaluated qualitative evidence on the experiences of MBC survivors to understand how they cope with associated challenges.

A cross-sectional study evaluated oncology nurses' readiness, knowledge, and confidence in incorporating genomics into practice to identify educational needs for cancer care.

SM-AML can remain occult until cytoreduction shows MC proliferation, highlighting a potential role for SM evaluation in KIT-positive AML.

Researchers evaluated the optimal duration of neoadjuvant radiotherapy for patients with locally advanced rectal cancer.

Epcoritamab combined with R-CHOP significantly improved progression free survival in patients with newly diagnosed DLBCL across both the primary endpoint and total populations.

A longitudinal study assessed cognitive trajectories in older and younger adults receiving CAR T-cell therapy for large B-cell lymphoma.

Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...